Trials / Completed
CompletedNCT05950243
COVID-19 Disease & Vaccine Survey in Africa
COVID-19 Disease & Vaccine Survey in Sub-Saharan Africa
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Salem Anaesthesia Pain Clinic · Academic / Other
- Sex
- All
- Age
- 9 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
The COVID-19 pandemic is a public health concern; for which the WHO recommends protective measures and vaccination. There is inadequate data on the impact of COVID-19 vaccination and control measures in Africa. This survey is collecting data about people's knowledge, attitude and compliance regarding COVID-19 disease and vaccines.
Detailed description
The coronavirus disease 2019 (COVID-19) pandemic remains a major public health concern. There is inadequate data on the epidemiology of COVID-19 in Africa. There are emerging COVID-19 variants with high transmissibility and morbidity. The World Health Organization (WHO) recommends protective measures and vaccination; for the control of COVID-19. There is inadequate data on the impact of COVID-19 vaccination and control measures in many nations in Africa. This study is a survey of specific urban populations in sub-Saharan Africa. The anonymized survey is collecting data about people's knowledge and attitude regarding COVID-19 disease or control measures. The survey is also collecting data about people's knowledge, attitude and compliance regarding COVID-19 vaccines. The study uses a validated questionnaire to collect data. The study aims to inform and improve COVID-19 management or control in Africa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Questionnaire | Questionnaire survey for data collection |
Timeline
- Start date
- 2021-01-02
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2023-07-18
- Last updated
- 2025-01-27
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05950243. Inclusion in this directory is not an endorsement.